References GLP-1 medications here refers to medications built on a GLP-1 backbone, but could also mean GLP-1 based medications that target glucagon receptor (GCGR) and glucose-dependent insulinotropic polypeptide receptor (GIPR) Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018
Research the exchange rate
Some people will still prefer injections, but for others, tablets may feel easier to fit into everyday life and more realistic to maintain long term
The combination of potent HbA1c reduction, minimal hypoglycemia risk, and cardiovascular benefit makes these agents the preferred glucose-lowering option for most patients with type 2 diabetes
A patient considering a GLP-1 drug should be able to answer these questions honestly before starting: Has a qualified endocrinologist or physician evaluated my overall metabolic health, not just my weight
doi: 10.2147/DMSO.S425642